Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paraneoplastic Neurological Syndromes”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Not applicableStudy completedNCT00004832
What this trial is testing

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

Who this might be right for
Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development 26
Not applicableStudy completedNCT05324176
What this trial is testing

Diaphragm Thickness by Ultrasonography in Neurological Disorders

Who this might be right for
Guillain-Barre SyndromeMyasthenia Gravis
Mansoura University 60
Not applicableActive Not RecruitingNCT06002945
What this trial is testing

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

Who this might be right for
Myasthenia Gravis
Yale University 400
Not applicableStudy completedNCT03490539
What this trial is testing

Disease-Modifying Treatments for Myasthenia Gravis

Who this might be right for
Neurological DisorderAutoimmune Diseases
Duke University 167
Testing effectiveness (Phase 2)Study completedNCT02591901
What this trial is testing

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

Who this might be right for
UTINeurogenic BladderAntibiotic Resistance
Buckinghamshire Healthcare NHS Trust 48
Testing effectiveness (Phase 2)Study completedNCT02343211
What this trial is testing

Immunotherapy and Paraneoplastic Neurological Syndromes

Who this might be right for
Paraneoplastic Neurological Syndromes
Assistance Publique - Hôpitaux de Paris 17
Early research (Phase 1)Study completedNCT05451212
What this trial is testing

Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis

Who this might be right for
MuSK Myasthenia Gravis
Cabaletta Bio 7
Not applicableUnknownNCT05225883
What this trial is testing

GWAS in NMDAR Encephalitis

Who this might be right for
Autoimmune Encephalitis
Hospices Civils de Lyon 2,000
Not applicableEnrolling By InvitationNCT00704626
What this trial is testing

Serum Auto-Antibodies in Neurological Diseases

Who this might be right for
Multiple SclerosisMyasthenia GravisTransverse Myelitis
University of California, Davis 120
Not applicableUnknownNCT03963700
What this trial is testing

Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)

Who this might be right for
CancerParaneoplastic SyndromesNeurologic Disorder+2 more
Hospices Civils de Lyon 980
Not applicableEnded earlyNCT00004682
What this trial is testing

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
University of Texas 100
Not applicableStudy completedNCT00587106
What this trial is testing

Studies of Neurological Paraneoplastic Syndromes

Who this might be right for
Paraneoplastic Neurologic Degenerations (PNDs)
Memorial Sloan Kettering Cancer Center 51
Post-approval studies (Phase 4)Study completedNCT00179478
What this trial is testing

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Who this might be right for
Multiple SclerosisOptic NeuritisTransverse Myelitis+1 more
Beth Israel Deaconess Medical Center 155
Not applicableStudy completedNCT04708626
What this trial is testing

Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden

Who this might be right for
Autoimmune EncephalitisParaneoplastic Neurological Syndrome
Uppsala University 110
Testing effectiveness (Phase 2)Study completedNCT00244361
What this trial is testing

Effectiveness of Rituximab in Pediatric OMS Patients.

Who this might be right for
Opsoclonus-myoclonus SyndromeOpsoclonusMyoclonus+1 more
National Pediatric Neuroinflammation Organization, Inc. 25
Not applicableStudy completedNCT05945784
What this trial is testing

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Who this might be right for
Stroke, IschemicStroke HemorrhagicStroke (CVA) or TIA+11 more
Casa Colina Hospital and Centers for Healthcare 57
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Daishi Tian 36
Early research (Phase 1)Looking for participantsNCT06869278
What this trial is testing

LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases

Who this might be right for
Multiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disease (NMOSD)Anti-Myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders (MOGAD)+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 37
Not applicableStudy completedNCT05942872
What this trial is testing

CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

Who this might be right for
Paraneoplastic Syndromes
Hospices Civils de Lyon 90
Early research (Phase 1)Not Yet RecruitingNCT07304154
What this trial is testing

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

Who this might be right for
Chronic Inflammatory Demyelinating PolyneuropathyMyasthenia GravisMultiple Sclerosis
Kite, A Gilead Company 52
Load More Results